• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of a week's beta-adrenoceptor blockade with atenolol and metoprolol CR/ZOK on the response to exercise in healthy women aged 50 to 70 years.

作者信息

Patrick J, Bassey J, Morrant J, Macdonald I

机构信息

Department of Physiology and Pharmacology, University of Nottingham Medical School, UK.

出版信息

J Clin Pharmacol. 1990 Feb;30(S2):S108-16. doi: 10.1002/j.1552-4604.1990.tb03507.x.

DOI:10.1002/j.1552-4604.1990.tb03507.x
PMID:2312773
Abstract

12 healthy women with a mean age of 60 years (range 50-70 years) were treated with 50 mg atenolol or 100 mg metoprolol CR/ZOK or placebo for 1 week in a double-blind, randomized, cross-over study. Laboratory measurements of the cardiovascular responses to exercise were made 2-4 hours after and again 24 hours after the last tablet. Blood pressure and heart rate at rest were reduced equally by the two beta-adrenoceptor antagonists. The reductions in blood pressure and heart rate during graded exercise and then during prolonged steady treadmill exercise 3-4 hours after the tablet were greater for atenolol than metoprolol CR/ZOK. The reductions in cardiac output showed a similar pattern. Lactate concentrations and ratings of perceived exertion tended to be highest on metoprolol CR/ZOK, but these differences were inconsistent. We conclude that despite the changes in the cardiovascular system in these 50-70 year-old women, exercise tolerance was not greatly affected by beta-adrenoceptor blockade.

摘要

相似文献

1
Effects of a week's beta-adrenoceptor blockade with atenolol and metoprolol CR/ZOK on the response to exercise in healthy women aged 50 to 70 years.
J Clin Pharmacol. 1990 Feb;30(S2):S108-16. doi: 10.1002/j.1552-4604.1990.tb03507.x.
2
Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.β-肾上腺素能受体阻滞剂与中枢神经系统相关主观症状:美托洛尔缓释片/佐剂、阿替洛尔和普萘洛尔长效制剂在健康受试者中的随机、双盲、安慰剂对照比较
J Clin Pharmacol. 1990 Feb;30(S2):S103-7. doi: 10.1002/j.1552-4604.1990.tb03506.x.
3
Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.服用阿替洛尔、高剂量和低剂量美托洛尔控释片/琥珀酸盐以及安慰剂的健康志愿者的运动代谢。
Br J Clin Pharmacol. 1994 Dec;38(6):499-504. doi: 10.1111/j.1365-2125.1994.tb04390.x.
4
Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol.控释(CR/ZOK)美托洛尔在健康东方受试者中的药代动力学和药效学特性:与美托洛尔和阿替洛尔常规制剂的比较。
J Clin Pharmacol. 1990 Feb;30(S2):S39-45. doi: 10.1002/j.1552-4604.1990.tb03494.x.
5
A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.每日一次服用美托洛尔控释片与阿替洛尔治疗中国轻至中度高血压患者的双盲比较。
Cardiovasc Drugs Ther. 1995 Jun;9(3):401-6. doi: 10.1007/BF00879028.
6
A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
J Clin Pharmacol. 1990 Feb;30(S2):S72-7. doi: 10.1002/j.1552-4604.1990.tb03500.x.
7
Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?美托洛尔缓释片/佐剂比传统美托洛尔和阿替洛尔更具选择性吗?
J Clin Pharmacol. 1990 Feb;30(S2):S98-102. doi: 10.1002/j.1552-4604.1990.tb03505.x.
8
Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.美托洛尔控释/缓释片每日一次与普通片剂每日一次及分次给药的药代动力学和药效学比较。
J Clin Pharmacol. 1990 Feb;30(S2):S17-27. doi: 10.1002/j.1552-4604.1990.tb03491.x.
9
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.控释美托洛尔制剂。其药效学和药代动力学特性以及在高血压和缺血性心脏病治疗中的应用综述。
Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006.
10
Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
J Clin Pharmacol. 1990 Feb;30(S2):S82-90. doi: 10.1002/j.1552-4604.1990.tb03502.x.

引用本文的文献

1
A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.每日一次服用美托洛尔控释片与阿替洛尔治疗中国轻至中度高血压患者的双盲比较。
Cardiovasc Drugs Ther. 1995 Jun;9(3):401-6. doi: 10.1007/BF00879028.
2
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.控释美托洛尔制剂。其药效学和药代动力学特性以及在高血压和缺血性心脏病治疗中的应用综述。
Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006.